These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11131930

  • 1. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
    Cowley AJ, Wiens BL, Segal R, Rich MW, Santanello NC, Dasbach EJ, Pitt B, ELITE Investigators. Evaluation of Losartan in the Elderly.
    Qual Life Res; 2000; 9(4):377-84. PubMed ID: 11131930
    [Abstract] [Full Text] [Related]

  • 2. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
    Pitt B, Poole-Wilson P, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B.
    J Card Fail; 1999 Jun; 5(2):146-54. PubMed ID: 10404354
    [Abstract] [Full Text] [Related]

  • 3. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI.
    Lancet; 1997 Mar 15; 349(9054):747-52. PubMed ID: 9074572
    [Abstract] [Full Text] [Related]

  • 4. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
    Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B.
    Lancet; 2000 May 06; 355(9215):1582-7. PubMed ID: 10821361
    [Abstract] [Full Text] [Related]

  • 5. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA, Patten RD, Thomas I, Ramahi T, La Bresh K, Goldman S, Lewis W, Gradman A, Self KS, Bittner V, Rand W, Kinan D, Smith JJ, Ford T, Segal R, Udelson JE.
    Am Heart J; 2000 Jun 06; 139(6):1081-7. PubMed ID: 10827391
    [Abstract] [Full Text] [Related]

  • 6. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
    Houghton AR, Harrison M, Cowley AJ.
    Eur J Heart Fail; 1999 Dec 06; 1(4):385-93. PubMed ID: 10937952
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 06; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 8. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
    Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group.
    Lancet; 2002 Sep 07; 360(9335):752-60. PubMed ID: 12241832
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of losartan and captopril in ELITE II.
    Hall A.
    Lancet; 2000 Sep 02; 356(9232):851; author reply 852-3. PubMed ID: 11022946
    [No Abstract] [Full Text] [Related]

  • 14. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
    Lynch JJ, Stump GL, Wallace AA, Painter CA, Thomas JM, Kusma SE, Gould RJ, Grossman W.
    J Am Coll Cardiol; 1999 Sep 02; 34(3):876-84. PubMed ID: 10483973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure.
    Dasbach EJ, Rich MW, Segal R, Gerth WC, Carides GW, Cook JR, Murray JF, Snavely DB, Pitt B.
    Cardiology; 1999 Sep 02; 91(3):189-94. PubMed ID: 10516413
    [Abstract] [Full Text] [Related]

  • 17. Is losartan superior to captopril in reducing all-cause mortality in elderly patients with symptomatic heart failure?
    Trojian TH, Jackson EA.
    J Fam Pract; 2000 Aug 02; 49(8):759-60. PubMed ID: 10947144
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.